CBP-1008

NEW

Please request pricing for this article.
Request Pricing

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-TP2953-10mg	10 mg	-	-	-	7 - 10 business days*		-
TGM-TP2953-50mg	50 mg	-	-	-	7 - 10 business days*		-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: CBP-1008 is a dual-ligand peptide-drug conjugate (PDC) with MMAE, targeting folate... more

Close menu

Product information "CBP-1008"

Description: CBP-1008 is a dual-ligand peptide-drug conjugate (PDC) with MMAE, targeting folate receptor (FRalpha) and TRPV6. It exhibits high binding affinity to FRalpha and low affinity to TRPV6. CBP-1008 shows antitumor activity and can be utilized for research in advanced solid tumors such as colorectal cancer, breast cancer, non-small cell lung cancer, ovarian cancer, adrenocortical carcinoma, and follicular dendritic cell sarcoma. Target: TRP/TRPV Channel

Supplier:	TargetMol
Supplier-Nr:	TP2953

Properties

Conjugate:

Database Information

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "CBP-1008"

Write a review